Assessment and management of cervico-mediastinal goiter

Assessment and management of cervico-mediastinal goiter

G Model ANORL-678; No. of Pages 5 ARTICLE IN PRESS European Annals of Otorhinolaryngology, Head and Neck diseases xxx (2017) xxx–xxx Available onlin...

1MB Sizes 0 Downloads 125 Views

G Model ANORL-678; No. of Pages 5

ARTICLE IN PRESS European Annals of Otorhinolaryngology, Head and Neck diseases xxx (2017) xxx–xxx

Available online at

ScienceDirect www.sciencedirect.com

Review

Assessment and management of cervico-mediastinal goiter E. Brenet ∗ , X. Dubernard , J.C. Mérol , M.A. Louges , M. Labrousse , M. Makeieff Département d’otorhinolaryngologie et chirurgie cervico-faciale, CHU de Reims, 45, rue Cognacq-Jay, 51092 Reims cedex, France

a r t i c l e

i n f o

Keywords: Goiter Sternotomy Retrograde dissection of the inferior laryngeal nerve

a b s t r a c t Cervico-mediastinal goiter is a particular entity from the point of view of thyroid surgery. Its volume, hardness and intrathoracic extension require the surgeon to adapt technique and perform a painstaking preoperative work-up, so as to draw up fully-fledged plan. CT is now indispensable, to anticipate risks and determine whether sternotomy is needed. Surgery seems to induce more postoperative complications than in conventional surgery, although they can be reduced by retrograde dissection of the inferior laryngeal nerve and downward dissection of the posterior side of the lobe to optimize control of adjacent structures. This surgery requires optimal teamwork between all of the specialties involved in patient management: medical, radiological, anesthesiological and surgical. © 2017 Elsevier Masson SAS. All rights reserved.

1. Introduction Thyroidectomy is a well-codified procedure under normal circumstances, but the presence of substernal goiter (SSG) requires the surgeon to adapt technique intraoperatively [1,2]. SSG is defined clinically and/or radiologically as extension of the thyroid below the sternal fork when the patient is in supine position [3]. This is an anatomic definition and does not help the surgeon anticipate intraoperative problems. It may not be possible to palpate the inferior end of the goiter in the lower part of the neck without aggravating the difficulty of surgery. The scope of difficult thyroidectomy has recently been updated to include SSG [4], covering factors liable to cause surgical problems: • topographic: cervico-thoracic and ectopic intrathoracic goiter; • technical: auto-immune thyroiditis, locally advanced cancer, recurrence; • anatomic: “non-recurrent recurrent nerve”, preoperative recurrent nerve palsy. We thus define SSG as a thyroid gland with inferior prolongation necessitating specific extraction maneuvers liable to increase surgical risk. Two entities can be distinguished in SSG: cervico-thoracic goiter (CTG) and intrathoracic goiter (ITG), the latter featuring the development of ectopic thoracic thyroid tissue, with no continuity with

the cervical tissue. CTG shows exclusively thyroid vascularization, whereas ITC is not only more rare (< 1% of goiters) but also shows specifically thoracic vascularization (internal thoracic artery, aorta, etc.) [4], and thus comes within the field of thoracic surgery, with specific approaches [5]. 2. Pathophysiology Causes leading to goiter are multiple: genetic, toxic (smoking), natural (manioc) and environmental (iodine deficiency), autoimmune thyroid disease and cancerous, hormonal or infiltrating pathology [6]. Thoracic extension in CTG is progressive, toward regions of lower anatomic resistance behind and forward of the supra-aortic vessels. Anterior extension is the most frequent at about 75% of CTGs [4]. It is more rapidly compressive, hindered in its inferior development by the brachiocephalic artery. CTGs with posterior development can become quite large, without clinical impact or symptoms, as there is a large space posterior to the brachiocephalic artery. Leftward development of posterior goiter is blocked inferiorly by the aortic cross and laterally by the common carotid and subclavian arteries (Fig. 1), and extension is rather inter-tracheoesophageal or retro-esophageal, giving rise to a typical scarf aspect. This form is rare, but not altogether exceptional at about 3% of cases; it makes surgery especially complex. 3. Preoperative work-up [7] 3.1. Clinical assessment

∗ Corresponding author. 6, rue de l’Ecu, 51100 Reims, France. E-mail address: [email protected] (E. Brenet).

The most common symptom is dyspnea, found in 59% of cases: in 39% as a feeling of being short of breath and in 20% as positional

http://dx.doi.org/10.1016/j.anorl.2017.06.001 1879-7296/© 2017 Elsevier Masson SAS. All rights reserved.

Please cite this article in press as: Brenet E, et al. Assessment and management of cervico-mediastinal goiter. European Annals of Otorhinolaryngology, Head and Neck diseases (2017), http://dx.doi.org/10.1016/j.anorl.2017.06.001

G Model ANORL-678; No. of Pages 5

ARTICLE IN PRESS E. Brenet et al. / European Annals of Otorhinolaryngology, Head and Neck diseases xxx (2017) xxx–xxx

2

Fig. 3. Contrast-enhanced cervico-thoracic CT, axial slice: large substernal goiter extending under the aortic arch.

Fig. 1. Cervico-thoracic region: goiter extension, paths (right and left arrows). Right: passage behind brachiocephalic artery (white star). Left: downward extension blocked by aortic arch (black star) and common carotid artery (white hexagon), therefore passing behind the esophagus or trachea.

dysthyroidism, which is a risk factor for surgical difficulties [4]. Thyroglobulin assay is not recommended. Calcitonin assay is performed preoperatively in case of suspected risk of thyroid medullary carcinoma [7]; false positives underlying calcitonin elevation comprise Hashimoto thyroiditis, chronic kidney failure, or hypercalcemia [14,15]. 3.3. Radiologic work-up

Fig. 2. Cervico-thoracic goiter, patient in operative position: obese short-necked patient; Note superficial venous circulation, indicating superior vena cava syndrome.

dyspnea. The second most frequent symptom is dysphagia, found in 43% of cases, mainly concerning solids, and sometimes associated with pharyngolaryngeal reflux [8]. Dysphonia is less frequent, but requires preoperative indirect laryngoscopy to assess vocalfold mobility; this examination is especially important in revision surgery or if the patient has already undergone cervico-thoracic surgery [9]. Goiter volume is assessed on the WHO classification. Contrastenhanced cervico-thoracic CT scan is recommended to screen for substernal extension, if the goiter is not entirely palpable, notably in patients who are obese, have a short neck or present kyphoscoliosis [10]. Superior vena cava syndrome is found directly in 5–9% of cases [8,11] (Fig. 2), or may be revealed by Pemberton’s maneuver, with the face turning crimson when the patient holds his or her arms above the head for a few minutes [12,13]. 3.2. Biological work-up Assays of TSH, thyroid hormones and TSH-receptor, thyroperoxidase and thyroglobulin antibodies reveal autoimmune

First-line imaging is by ultrasound, even in clinically manifest goiter [16]. Fine-needle aspiration of ultrasound-suspect nodules follows the indications for management of a normal-sized thyroid [17]. An intracavity probe assesses substernal extension. Contrast-enhanced CT scan is the gold-standard for cervicomediastinal exploration. Vascular exploration focuses in detail on the relations between the goiter and the aortic arch, common carotid artery, brachiocephalic artery, subclavian artery and the two brachiocephalic veins. Goiter descending below the aortic arch is difficult to extract and thus entails a risk of sternotomy [18] (Fig. 3). Exploration screens for a retro-esophageal subclavian artery that may be induce dysphagia lusoria and is systematically associated with a “nonrecurrent right recurrent” nerve, originating from the vagus nerve in the upper neck, which is a major surgical pitfall [19]. Digestive exploration screens for tracheo-esophageal dissociation in case of “scarf goiter” and also for radiologic tracheal compression, found in 35–97% of cases, depending on the report [8,20]. Surgery is indicated for ≥ 35% tracheal stenosis and achieves significant alleviation of dyspnea in 95–98% of cases. In < 35% stenosis, surgery is indicated only in case of clinical symptoms or in young patients to prevent any potentially harmful medium-to-long-term progression [20]. Iodine-131 scintigraphy is recommended only if TSH levels are below normal. 4. Revelation and surgical indications Age is the first parameter to consider. Asymptomatic goiter in a patient of advanced physiological age is not in itself an indication for surgery. In young patients, on the other hand, the risk of the goiter growing and becoming compressive or malignant justify surgery even in the absence of symptoms [21]. In case of symptom onset, a complete assessment work-up is mandatory. Acute respiratory distress, dysphagia or signs of vascular compression provide brutal revelation and require rapid and difficult treatment. Such situations may arise with an episode of hyperthyroidism, hematocele or oncologic degeneration (e.g., anaplasia). It is estimated that 1–3% of patients with untreated plunging goiter

Please cite this article in press as: Brenet E, et al. Assessment and management of cervico-mediastinal goiter. European Annals of Otorhinolaryngology, Head and Neck diseases (2017), http://dx.doi.org/10.1016/j.anorl.2017.06.001

G Model

ARTICLE IN PRESS

ANORL-678; No. of Pages 5

E. Brenet et al. / European Annals of Otorhinolaryngology, Head and Neck diseases xxx (2017) xxx–xxx

die from respiratory causes, whence the need to operate on young asymptomatic patients [22,23]. CT assessment is essential, to identify the goiter and its vascular relations and detect any invasion of the visceral axis that might lead to tumoral transformation, such as anaplasia, often contraindicating surgery [10]. In patients with history of surgery, scar tissue in the thyroid fossa promotes development of the goiter toward the cervicothoracic isthmus on remaining or overlooked thyroid tissue [1,17,23]. Finally, it is important during the work-up to identify any factors predictive of need for sternotomy. Clinically, SSG of more than 160 months’ progression is an important risk factor. Radiologically, high thyroid tissue density, retrovascular goiter location and extension below the carina increase the risk of sternotomy, with relative risk of 47.3, 10.5 and 20.5, respectively [24]. Other sternotomy risk factors have been reported: extension below the aortic arch (PPV, 54%; NPV, 97%), predominantly right-side location (PPV, 21%; NPV, 95%), or retrotracheal location [25]. Surgical indications should systematically be discussed in the multidisciplinary team, taking account of the opinions of the patient’s physician, the patient, the endocrinologist, the anesthesiologist and the cervical and thoracic surgeons [18]. 4.1. Preoperative thoracic consultation and patient information Sternotomy is rare, at 1% to 3% of cases [4,18,26], but needs to be anticipated. A preoperative consultation with the thoracic surgeon is recommended in case of history of radiation therapy or neck surgery, suspected malignancy with extra-thyroidal extension, extension below the aortic arch or to the posterior mediastinum, or ectopic mediastinal goiter without connection to the cervical goiter [7]. The consultation allows the patient to be informed of the possibility, modalities and consequences of sternotomy [18,27]. 5. Cervico-thoracic goiter surgery Cervico-thoracic goiter surgery is complex and can only be performed in reference centers with experienced surgical and anesthesiological teams [28,29]. 5.1. Intubation Intubation is performed by an experienced anesthesiologist in difficult indications, although SSG entails no specific difficulties of intubation [30]. The surgeon should be on hand during induction, and teamwork with the anesthesiologist should be optimal. In case of foreseeable difficulties (with pharyngolaryngeal involvement or obesity), intubation should be performed with the patient awake, under flexible endoscopy [31]. A probe is positioned to monitor recurrent nerve activity [32]. 5.2. Surgery The objective is to extract the entire goiter through a cervical approach, with optimal control of large vessels. Cervico-thoracic goiter surgery differs from conventional thyroid surgery in two ways: it includes location and retrograde dissection of the inferior laryngeal nerve and raising the goiter to the cervical region through the anterior part of the superior thoracic orifice. The veins in particular are exposed: notably, the brachiocephalic vein in anterior goiter and the azygos vein in deep goiter. Controlling vascular problems before raising the goiter can be difficult and chancy and may require emergency sternotomy to enable access [33]. It is therefore important for the surgeon to be precisely

3

aware of vessel size, prolongations and relations to large vessels [33,34]. The patient is positioned with the arm along the body and neck in hyperextension, with a support under the shoulders if necessary. A medial cervical incision of a length corresponding to the goiter is made along the sternal manubrium. When the cervical white line is found, it is incised from the hyoid bone down to the sternal manubrium. The superficial and deep infrahyoid muscles are pulled aside by retractors after release from the thyroid capsule underneath and may be sectioned if exposure requires. Dissection begins on the less plunging side, performing the first lobotomy then freeing the anterior and lateral side of the trachea by sectioning Grüber’s ligament to the contralateral side. Dissection then continues downward, releasing the anterior part of the goiter from its tracheal attachments, allowing a second step, which is to raise the thoracic prolongation of the goiter. The superior end of the lobe is exposed and the superior thyroid artery is ligated, taking care not to involve the superior laryngeal nerve, which sometimes descends to a greater or lesser extent on the superior end of the lobe and can easily be injured if it becomes detached. A traction wire is positioned on the superior end of the lobe. Dissecting the superior end provides access to the posterior retrothyroid plane and lateral side of the lobe. The inferior laryngeal nerve is then located, moving downward from its entry point in the larynx. This retrograde dissection enables the nerve to be located and dissected when it is not exposed laterally by inclining the lobe. Goiters may be too large and hard for a conventional technique without risk of recurrent nerve lesion [2,10,35]. The inferior laryngeal nerve is located under the edge of the cricoid cartilage and just behind the inferior horn of the thyroid cartilage. The cricopharyngeal muscle, covering the cricoid is followed down to its inferior edge, from which the inferior laryngeal nerve has to be explored downward. The lobe, held down by a retractor, delineates a triangular anatomic area comprising the inferior edge of the cricopharyngeal muscle above, the trachea within and the esophagus below. This stage of dissection is closest to the nerve, adherent to the thyroid capsule and hemostasis should, if possible, be avoided until the inferior laryngeal nerve has been identified. Once identification has been confirmed by neurostimulation, the nerve is followed downward. This retrograde dissection significantly reduces the risk of transient or permanent inferior laryngeal nerve palsy in goiter surgery [2]. The thyrotracheal attachments are then sectioned and the inferior thyroid artery is located, ligated and sectioned (Fig. 4). The plunging part of the goiter is then lifted by the index finger, which is placed on the capsule, and slid along the posterolateral side of the lobe down to the inferior end then up over the anterior side until a resistance, indicating the inferior thyroid veins, is encountered (Fig. 5). The lobe is raised and the veins are controlled after “delivering” the lobe. Bleeding occurring before extraction can hinder control [36] and this is when sternotomy may become necessary. Drains may not be necessary and do not reduce compressive cervical hematoma or provide faster detection [37], but are used with obese patients or in case of kyphoscoliosis, where clinical surveillance is less reliable [38]. Closure is then performed in the classical way.

6. Postoperative course Surveillance should be close during the first 24 hours. Extubation is performed in the operating room, in presence of the surgeon. Tracheomalacia secondary to cartilage ring compression by the goiter is very rare. Techniques such as tracheal resection-anastomosis, endotracheal implant or tracheopexy are

Please cite this article in press as: Brenet E, et al. Assessment and management of cervico-mediastinal goiter. European Annals of Otorhinolaryngology, Head and Neck diseases (2017), http://dx.doi.org/10.1016/j.anorl.2017.06.001

G Model ANORL-678; No. of Pages 5 4

ARTICLE IN PRESS E. Brenet et al. / European Annals of Otorhinolaryngology, Head and Neck diseases xxx (2017) xxx–xxx

Thyroid hormone replacement is initiated on the day after surgery, at 1.4–1.6 ␮g/kg/day. TSH assay at 4–6 weeks guides replacement dosage. 7. Conclusion

Fig. 4. Release of thyroid lobe after retrograde inferior laryngeal nerve dissection (arrow) and control of inferior thyroid artery (star).

Cervico-thoracic goiter is a particular entity in thyroid surgery. Its volume, hardness and intrathoracic extension require the surgeon to adapt technique and above all, perform thorough preoperative assessment so as to draw up a full intervention plan. CT is now indispensable, enabling the patient to be given clear an appropriate information concerning risks and notably sternotomy. Postoperative complications seem to be more common than in classical thyroid surgery, but retrograde inferior laryngeal nerve dissection and downward dissection of the posterior side of the lobe enable good control of critical structures and reduce the rate of complications. The procedure requires optimal cooperation between all those involved, on the medical, radiological, anesthesiological and surgical levels. Disclosure of interest The authors declare that they have no competing interest. References

Fig. 5. Finger ascension of plunging party of goiter along the thyroid capsule.

rarely needed. In the vast majority of cases of tracheomalacia, symptoms were present preoperatively, in the form of stridor with symmetrically mobile vocal folds. Postoperative respiratory distress or stridor in preoperatively asymptomatic patients suggests intraoperative recurrent nerve injury, requiring emergency flexible endoscopy [31,32]. The risk of recurrent nerve injury is greater than in classical thyroid surgery, at 2–10% [21,30,35,39,40]. The nerve may get stretched during extraction, especially on the right, or get sectioned if it is adherent to the goiter. The risk is greatly increased by sternotomy, with 3–8% definitive recurrent nerve palsy [10,29,30,40,41]. The risk of parathyroid gland lesion is also greater than in classical thyroid surgery. The glands can be hard to locate, especially the inferior parathyroid (P3), which often adheres to the deep side of the goiter, very low at the cervico-thoracic junction. It is easily injured during extraction and subsequent dissection if vessel ligation is not performed in contact with the capsule. Immediate hypoparathyroidism is very common in bilateral procedures, but generally resolves quickly. Persistent hypoparathyroidism is more frequent than in surgery for strictly cervical goiter, with a rate of around 2.8% [42,43]. The risk is greater in revision surgery, where dissection is more difficult, making parathyroid vascularization more difficult to conserve. Postoperative PTH assay guides requirements for calcium or vitamin D supplementation [44,45].

[1] Huins CT, Georgalas C, Mehrzad H, Tolley NS. A new classification system for retrosternal goitre based on a systematic review of its complications and management. Int J Surg Lond Engl 2008;6(1):71–6. [2] Makeieff M, Marlier F, Khudjadze M, Garrel R, Crampette L, Guerrier B. Substernal goiter. Report of 212 cases. Ann Chir 2000;125(1):18–25. [3] Hedayati N, McHenry CR. The clinical presentation and operative management of nodular and diffuse substernal thyroid disease. Am Surg 2002;68(3):245–51 [discussion 251-2]. [4] Pellizzo MR. Difficult thyroidectomies. Il G Chir 2015;36(2):49–56. [5] Houck WV, Kaplan AJ, Reed CE, Cole DJ. Intrathoracic aberrant thyroid: identification critical for appropriate operative approach. Am Surg 1998;64(4):360–2. [6] Medeiros-Neto G, Camargo RY, Tomimori EK. Approach to and treatment of goiters. Med Clin North Am 2012;96(2):351–68. [7] Chen AY, Bernet VJ, Carty SE, Davies TF, Ganly I, Inabnet WB, et al. American thyroid association statement on optimal surgical management of goiter. Thyroid Off J Am Thyroid Assoc 2014;24(2):181–9. [8] Shen WT, Kebebew E, Duh Q-Y, Clark OH. Predictors of airway complications after thyroidectomy for substernal goiter. Arch Surg Chic Ill 1960 2004;139(6):656–9 [discussion 659-60]. [9] Randolph GW, Kamani D. The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function and the preoperative detection of invasive thyroid malignancy. Surg 2006;139(3):357–62. [10] White ML, Doherty GM, Gauger PG. Evidence-based surgical management of substernal goiter. World J Surg 2008;32(7):1285–300. [11] Sancho JJ, Kraimps JL, Sanchez-Blanco JM, Larrad A, Rodríguez JM, Gil P, et al. Increased mortality and morbidity associated with thyroidectomy for intrathoracic goiters reaching the carina tracheae. Arch Surg Chic Ill 1960 2006;141(1):82–5. [12] Pemberton JD, Willius FA. Cardiac features of goitre: with special reference to operation. Ann Surg 1932;95(4):508–16. [13] O’Brien KE, Gopal V, Mazzaferri E. Pemberton’s sign associated with a large multinodular goiter. Thyroid Off J Am Thyroid Assoc 2003;13(4):407–8. [14] Toledo SPA, Lourenc¸o DM, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE de M. Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clin São Paulo Braz 2009;64(7):699–706. [15] Telenius-Berg M, Almqvist S, Wästhed B. Serum calcitonin response to induced hypercalcemia. Acta Med Scand 1975;197(5):367–75. [16] American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancerCooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, et al. Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid, cancer. Thyroid 2009;19(11):1167–214. ˜ [17] Galinanes EL, Caron N. Remnant large retrosternal thyroid goiter after thyroidectomy. Am Surg 2012;78(4):E222–3. [18] Nankee L, Chen H, Schneider DF, Sippel RS, Elfenbein DM. Substernal goiter: when is a sternotomy required? J Surg Res 2015;199(1):121–5. [19] Katz AD, Nemiroff P. Anastamoses and bifurcations of the recurrent laryngeal nerve–report of 1177 nerves visualized. Am Surg 1993;59(3):188–91. [20] Stang MT, Armstrong MJ, Ogilvie JB, Yip L, McCoy KL, Faber CN, et al. Positional dyspnea and tracheal compression as indications for goiter resection. Arch Surg Chic Ill 1960 2012;147(7):621–6.

Please cite this article in press as: Brenet E, et al. Assessment and management of cervico-mediastinal goiter. European Annals of Otorhinolaryngology, Head and Neck diseases (2017), http://dx.doi.org/10.1016/j.anorl.2017.06.001

G Model ANORL-678; No. of Pages 5

ARTICLE IN PRESS E. Brenet et al. / European Annals of Otorhinolaryngology, Head and Neck diseases xxx (2017) xxx–xxx

[21] Sanders LE, Rossi RL, Shahian DM, Williamson WA. Mediastinal goiters. The need for an aggressive approach. Arch Surg Chic Ill 1960 1992;127(5):609–13. [22] Mack E. Management of patients with substernal goiters. Surg Clin North Am 1995;75(3):377–94. [23] Hsu B, Reeve TS, Guinea AI, Robinson B, Delbridge L. Recurrent substernal nodular goiter: incidence and management. Surg 1996;120(6):1072–5. [24] McKenzie GAG, Rook W. Is it possible to predict the need for sternotomy in patients undergoing thyroidectomy with retrosternal extension? Interact Cardiovasc Thorac Surg 2014;19(1):139–43. [25] Malvemyr P, Liljeberg N, Hellström M, Muth A. Computed tomography for preoperative evaluation of need for sternotomy in surgery for retrosternal goitre. Langenbecks Arch Surg Dtsch Ges Für Chir 2015;400(3):293–9. [26] Rolighed L, Rønning H, Christiansen P. Sternotomy for substernal goiter: retrospective study of 52 operations. Langenbecks Arch Surg Dtsch Ges Für Chir 2015;400(3):301–6. [27] Ayache S, Mardyla N, Tramier B, Strunski V. Post-operative complications and predictive factors in a series of 117 total thyroidectomies for substernal goiter. Rev Laryngol Otol Rhinol 2008;129(3):181–9. [28] Ho TWT, Shaheen AA, Dixon E, Harvey A. Utilization of thyroidectomy for benign disease in the United States: a 15-year population-based study. Am J Surg 2011;201(5):570–4. [29] Pieracci FM, Fahey TJ. Effect of hospital volume of thyroidectomies on outcomes following substernal thyroidectomy. World J Surg 2008;32(5):740–6. [30] Mackie TW, Skinner A. Anaesthesia for massive retrosternal thyroidectomy in a tertiary referral centre. Br J Anaesth 2014;112(4):756. [31] Bennett AMD, Hashmi SM, Premachandra DJ, Wright MM. The myth of tracheomalacia and difficult intubation in cases of retrosternal goitre. J Laryngol Otol 2004;118(10):778–80. [32] Randolph GW, Shin JJ, Grillo HC, Mathisen D, Katlic MR, Kamani D, et al. The surgical management of goiter: Part II. Surgical treatment and results. Laryngoscope 2011;121(1):68–76. [33] Porterfield JR, Thompson GB, Farley DR, Grant CS, Richards ML. Evidence-based management of toxic multinodular goiter (Plummer’s disease). World J Surg 2008;32(7):1278–84.

5

[34] Jennings A. Evaluation of substernal goiters using computed tomography and MR imaging. Endocrinol Metab Clin North Am 2001;30(2):401–14 [ix]. [35] Proye C, Dumont HG, Depadt G, Lagache G. The“non-recurrent” recurrent nerve danger in thyroid surgery. 15 cases. Ann Chir 1982;36(7):454–8. [36] Clark OH, Lal G. Novel technique for control of mediastinal bleeding during thyroidectomy for substernal goiter. J Am Coll Surg 2003;196(5):818–20. [37] Dunlap WW, Berg RL, Urquhart AC. Thyroid drains and postoperative drainage. Otolaryngol–Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 2010;143(2):235–8. [38] Carty SE, Doherty GM, Inabnet WB, Pasieka JL, Randolph GW, Shaha AR, et al. American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. Thyroid Off J Am Thyroid Assoc 2012;22(4): 395–9. [39] Dubost C, Roche JY, Celerier M. Intrathoracic diving goiters. Apropos of 50 cases. Ann Chir 1973;27(6):555–66. [40] Testini M, Gurrado A, Bellantone R, Brazzarola P, Cortese R, De Toma G, et al. Recurrent laryngeal nerve palsy and substernal goiter. An Italian multicenter study. J Visc Surg 2014;151(3):183–9. [41] Abboud B, Sleilaty G, Mallak N, Abou Zeid H, Tabchy B. Morbidity and mortality of thyroidectomy for substernal goiter. Head Neck 2010;32(6):744–9. [42] Michel LA, Donckier J. Compression syndromes caused by substernal goitres. Postgrad Med J 1998;74(877):701–2. [43] Netterville JL, Coleman SC, Smith JC, Smith MM, Day TA, Burkey BB. Management of substernal goiter. Laryngoscope 1998;108(11 Pt 1):1611–7. [44] Noordzij JP, Lee SL, Bernet VJ, Payne RJ, Cohen SM, McLeod IK, et al. Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. J Am Coll Surg 2007;205(6):748–54. [45] Wiseman JE, Mossanen M, Ituarte PHG, Bath JMT, Yeh MW. An algorithm informed by the parathyroid hormone level reduces hypocalcemic complications of thyroidectomy. World J Surg 2010;34(3):532–7.

Please cite this article in press as: Brenet E, et al. Assessment and management of cervico-mediastinal goiter. European Annals of Otorhinolaryngology, Head and Neck diseases (2017), http://dx.doi.org/10.1016/j.anorl.2017.06.001